Search research articles
Contact Us
Filters
Showing results (161-170 of 204) with videos related to
Page
of 21
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2026
Results from a prospective registry of <sup>18</sup>F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET
Steven Blinka, Risa L Wong, Sarah K Holt, et al.
Advances in Radiation Oncology
|
April 7, 2022
A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy
Matthew D Greer, Stephanie K Schaub, Stephen R Bowen, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
June 10, 2021
Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes
Leonidas N Diamantopoulos, Ali Raza Khaki, Petros Grivas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2017
Association of Tissue Abiraterone Levels and <i>SLCO</i> Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer
Elahe A Mostaghel, Eunpi Cho, Ailin Zhang, et al.
The American Journal of Managed Care
|
January 17, 2018
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay
Julie A Lynch, Megan P Rothney, Raoul R Salup, et al.
Clinical Genitourinary Cancer
|
January 29, 2023
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
Dimitrios Makrakis, Jonathan L Wright, Martine P Roudier, et al.
JCI Insight
|
May 31, 2019
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Brian R Winters, Navonil De Sarkar, Sonali Arora, et al.
Cancer Research
|
December 2, 2021
Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis
Weisi Xie, Nicholas P Reder, Can Koyuncu, et al.
European Urology
|
March 12, 2023
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
European Urology
|
August 14, 2022
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 204) with videos related to
Sort By:
Page
of 21
American Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2026
Results from a prospective registry of <sup>18</sup>F-Fluciclovine PET/CT use in prostate cancer management: a cautionary lesson for implementation of PSMA PET
Steven Blinka, Risa L Wong, Sarah K Holt, et al.
Advances in Radiation Oncology
|
April 7, 2022
A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy
Matthew D Greer, Stephanie K Schaub, Stephen R Bowen, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
June 10, 2021
Plasmacytoid urothelial carcinoma: response to chemotherapy and oncologic outcomes
Leonidas N Diamantopoulos, Ali Raza Khaki, Petros Grivas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 9, 2017
Association of Tissue Abiraterone Levels and <i>SLCO</i> Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer
Elahe A Mostaghel, Eunpi Cho, Ailin Zhang, et al.
The American Journal of Managed Care
|
January 17, 2018
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay
Julie A Lynch, Megan P Rothney, Raoul R Salup, et al.
Clinical Genitourinary Cancer
|
January 29, 2023
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer
Dimitrios Makrakis, Jonathan L Wright, Martine P Roudier, et al.
JCI Insight
|
May 31, 2019
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Brian R Winters, Navonil De Sarkar, Sonali Arora, et al.
Cancer Research
|
December 2, 2021
Prostate Cancer Risk Stratification via Nondestructive 3D Pathology with Deep Learning-Assisted Gland Analysis
Weisi Xie, Nicholas P Reder, Can Koyuncu, et al.
European Urology
|
March 12, 2023
Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
European Urology
|
August 14, 2022
Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer
Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, et al.
Page
of 21